Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Cardiovascular toxicity in metastatic prostate cancer treatment: balancing risks, treating consequences
Anno:
2024
INTRODUCTION Enzalutamide inhibits the receptor of androgen hormones. It is administered for treating metastasized prostate cancer. Enzalutamide is known to have a cardiotoxic effect. CASE REPORT A 76 year-old man on-treatment for hypertension and overall good health underwent radical prostatectomy and bilateral ileo-obturator lymphadenectomy in 2021 for prostate cancer….
Acute myocardial injury in a patient with type-1 neurofibromatosis: a case of suspected pheocromocytoma-associated myocarditis
Anno:
2024
A 54-year-old patient with an history of type-1 neurofibromatosis presented to the emergency department (ED) due to recurrent abdominal pain with diarrhea. Clinical examination didn’t show anything remarkable. She was mildly hypertensive, apyretic. During her staying in the ED, she complained about chest pain and an electrocardiogram (ECG) was…
THE TALK TEST AS A VALUABLE REHABILITATION TOOL IN PATIENTS WITH HEART FAILURE
Anno:
2024
Aim: to determine whether a rehabilitation program for heart failure patients in interval training, established by Talk Test, is more effective than the protocol in endurance training set by 6MWT. Materials and methods: For this retrospective study, 32 subjects with reduced left ventricular ejection fraction (LVF)…
Impact of new multiparameter algorithm for the management of heart failure patients with an ICD in terms of reduced hospitalization and role of the Cardiology Technician in telecardiology related to specific heart failure service – our experience
Anno:
2024
Introduction Heart failure represents an important cause of hospitalization and is associated with an increased cardiovascular risk for the patient as well as an increase in healthcare spending. In recent years, algorithms for detecting pre-heart failure subclinical changes have been developed for implantable defibrillator (ICD) users so as to…
PARTIALLY REVERSIBLE DILATED CARDIOMYOPATHY ASSOCIATED WITH AMPHOTERICIN B THERAPY
Anno:
2024
BACKGROUND Amphotericin B (AmB) is an antifungal drug commonly used in a broad spectrum of infections, including leishmaniasis. Leishmaniasis, transmitted through insect bites, has cutaneous, mucocutaneous, or visceral (particularly liver and spleen) involvement. The main adverse effects of AmB are cardiotoxicity and nephrotoxicity, often reversible, but with yet unclear…
HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) IN A PATIENT WITH RECENT TAVI AND NUMEROUS CORONARY FISTULAS OF THE LEFT CORONARY ARTERY DRAINING INTO THE VENTRICULAR CAVITY
Anno:
2024
Coronary fistula is a rare form of congenital heart disease and is defined as an abnormal connection between a coronary branch and a cardiac chamber or a large intrathoracic vessel without the interposition of the capillary circulation. The right coronary artery is the most common site of origin for…
A new project of a specific exercise protocolfor ambulatory cardiovascular rehabilitation specific for heart failure: report of the first experience
Anno:
2024
The indication to cardiovascular rehabilitation (CV rehab) was recently upgraded to I A in the European guidelines (GL) for the treatment of heart failure (HF), along with the four pharmacologic pillars. According to this change, we have implemented our CV rehab protocol to include specific exercises for patients (pts)…
Taking a walk on the heart failure side: comparison of metabolic variables during walking and maximal exertion
Anno:
2024
Background: Background: Although cardiopulmonary exercise testing (CPET) is the gold standard to assess exercise capacity, simpler tests (i.e. 6-minute walk test, 6MWT) are also commonly used. Aim of this study was to evaluate the relationship between cardiorespiratory parameters during CPET and 6MWT in a large, multicenter, heterogeneous population. Methods:…
MULTIDISCIPLINARY APPROACH TO A DIFFICULT CASE OF ACUTE HEART FAILURE DUE TO POSSIBILE ISOLATED CARDIAC SARCOIDOSIS
Anno:
2024
Background – Cardiac sarcoidosis (CS) is a rare, infiltrative cardiomyopathy that results from granulomatous inflammation affecting the heart with high morbidity and mortality. It is usually associated with a systemic (i.e. pulmonary) involvement, but lone heart involvement has been described. Even with extensive multidisciplinary evaluation making a firm diagnosis…
Overcoming extreme medical-surgical events, in carriers of CRTD and CCM. Clinical stabilization.
Anno:
2024
A 63-year-old male patient suffering from chronic dilated ischemic heart disease, with severe depression of contractility and estimated EF of 16%, carrier of CRT-D and CCM, in follow up at our center. Extreme events of medical/surgical interest have occurred in the last period: the patient underwent strangulated hernia surgery…